Replies to post #189602 on Biotech Values

[DewDiligence]

ICPT’s current pro forma cash balance is $769M less whatever has been burned since 3/31/14:

http://finance.yahoo.com/news/intercept-pharmaceuticals-announces-first-quarter-100100493.html

On the CC, ICPT re-iterated finalization of the phase-3 NASH trial during 2Q15.